Indicators

Latest News about NVS

Recent news which mentions NVS

< Previous 1 2 3 4 5 6 7 8 9

...

11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields

February 28, 2024

This Drug By Roche And Novartis Reduces Allergic Reactions Across Multiple Foods For People With Food Allergies

February 26, 2024

Looking Into Novartis's Recent Short Interest

February 22, 2024

Move Over Magnificent 7, Say Hello to the GRANOLAS

February 22, 2024

Exit Now! 3 Biotech Stocks to Sell in February 2024

February 21, 2024

7 Contrarian Biotech Stocks to Consider Amid Sector Weakness

February 15, 2024

The 3 Biotech Stocks That Could Make Your February Unforgettable

February 15, 2024

Biogen Could Engage In $1B-$2B Deals To Fill Revenue Shortfall Gaps, Analyst Says

February 14, 2024

JP Morgan's Bullish View On This Chinese Biotech, Says Pullback Creates Entry Point

February 06, 2024

Novartis Agrees To Acquire German Blood Cancer-Drug Developer MorphoSys For €2.7B

February 06, 2024

Why Is MorphoSys (MOR) Stock Up 50% Today?

February 05, 2024

MorphoSys Stock Soars After Report Says Novartis To Acquire Cancer-Drug Developer

February 05, 2024

3 Fabulous Dividend Stocks to Buy in February

February 04, 2024

Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations

February 02, 2024

Novartis Ag (NVS) Q4 2023 Earnings Call Transcript

January 31, 2024

Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

January 31, 2024

Why Is European Pharma Giant Novartis Stock Trading Lower Today?

January 31, 2024

Nasdaq Futures Plummet As Alphabet, AMD Disappointments Sour Sentiment; Spotlight Shifts To Fed Statement, Powell's Presser

January 31, 2024

Alphabet Reports Q4 Results, Joins AMD, Tesla And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

January 31, 2024

Earnings Scheduled For January 31, 2024

January 31, 2024

3 Hidden Healthcare Stocks Poised for a Breakout This Year

January 30, 2024

Earnings Outlook For Novartis

January 30, 2024

Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?

January 29, 2024

Gilead's Tecartus Dropped From FDA List Of CAR-T Therapy With Updated Label Warning Of "Risks Of Secondary Cancer'

January 24, 2024

Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment

January 23, 2024

Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst

January 12, 2024

Novartis Retreats From Cytokinetics Deal, Dashing Hopes For Multi-Billion Dollar Acquisition

January 11, 2024

What's Been Happening With Cytokinetics Stock?

January 09, 2024

Why Is Heart Failure Drug-Focused Cytokinetic Stock Trading Higher Today?

January 08, 2024

Why Is $7B Valued Cancer Focused Exelixis Trading Lower Today?

January 08, 2024

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.